000			01875 a2200529 4500
005			20250515201305.0
264		0	_c20100506
008			201005s 0 0 eng d
022			_a1432-1041
024	7		_a10.1007/s00228-009-0760-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aPolasek, Thomas M
245	0	0	_aIn vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A. _h[electronic resource]
260			_bEuropean journal of clinical pharmacology _cMar 2010
300			_a275-83 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aArea Under Curve
650	0	4	_aComputer Simulation
650	0	4	_aCytochrome P-450 CYP3A _xmetabolism
650	0	4	_aCytochrome P-450 CYP3A Inhibitors
650	0	4	_aCytochrome P-450 Enzyme Inhibitors
650	0	4	_aCytochrome P-450 Enzyme System _xmetabolism
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Interactions
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLiver _xdrug effects
650	0	4	_aMale
650	0	4	_aMetabolic Clearance Rate
650	0	4	_aMicrosomes, Liver _xenzymology
650	0	4	_aMidazolam _xadministration & dosage
650	0	4	_aModels, Biological
650	0	4	_aPyridines _xpharmacology
650	0	4	_aRecombinant Proteins _xantagonists & inhibitors
650	0	4	_aYoung Adult
650	0	4	_aZolpidem
700	1		_aSadagopal, Janani S
700	1		_aElliot, David J
700	1		_aMiners, John O
773	0		_tEuropean journal of clinical pharmacology _gvol. 66 _gno. 3 _gp. 275-83
856	4	0	_uhttps://doi.org/10.1007/s00228-009-0760-2 _zAvailable from publisher's website
999			_c19393903 _d19393903